(Q39422439)

English

Association between discordant immunological response to highly active anti-retroviral therapy, regulatory T cell percentage, immune cell activation and very low-level viraemia in HIV-infected patients.

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24460818%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

Association between discordant immunological response to highly active anti-retroviral therapy, regulatory T cell percentage, immune cell activation and very low-level viraemia in HIV-infected patients (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24460818%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

0 references

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24460818%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24460818%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

Delphine Maucort-Boulch

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24460818%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

author name string

J Saison

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24460818%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

T Ferry

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24460818%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

T Perpoint

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24460818%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

F Ader

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24460818%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

V Icard

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24460818%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

C Chidiac

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24460818%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

G Monneret

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24460818%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

Lyon HIV Cohort Study

11

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24460818%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

language of work or name

1 reference

based on heuristic

inferred from title

publication date

1 June 2014

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24460818%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

Clinical and Experimental Immunology

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24460818%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

176

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24460818%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24460818%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

401-409

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24460818%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

Long-term clinical outcome of human immunodeficiency virus-infected patients with discordant immunologic and virologic responses to a protease inhibitor-containing regimen

1 reference

https://api.crossref.org/works/10.1111%2FCEI.12278

21 January 2018

Discordant responses on starting highly active antiretroviral therapy: suboptimal CD4 increases despite early viral suppression in the UK Collaborative HIV Cohort (UK CHIC) Study

1 reference

https://api.crossref.org/works/10.1111%2FCEI.12278

21 January 2018

Incomplete immune recovery in HIV infection: mechanisms, relevance for clinical care, and possible solutions

1 reference

https://api.crossref.org/works/10.1111%2FCEI.12278

21 January 2018

Mortality in well controlled HIV in the continuous antiretroviral therapy arms of the SMART and ESPRIT trials compared with the general population

1 reference

https://api.crossref.org/works/10.1111%2FCEI.12278

21 January 2018

HIV and inflammation: mechanisms and consequences

1 reference

https://api.crossref.org/works/10.1111%2FCEI.12278

21 January 2018

T-cell homeostasis alteration in HIV-1 infected subjects with low CD4 T-cell count despite undetectable virus load during HAART.

1 reference

https://api.crossref.org/works/10.1111%2FCEI.12278

21 January 2018

Naive T-cell depletion related to infection by X4 human immunodeficiency virus type 1 in poor immunological responders to highly active antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1111%2FCEI.12278

21 January 2018

High T-cell immune activation and immune exhaustion among individuals with suboptimal CD4 recovery after 4 years of antiretroviral therapy in an African cohort

1 reference

https://api.crossref.org/works/10.1111%2FCEI.12278

21 January 2018

Differential alterations of the CD4 and CD8 T cell subsets in HIV-infected patients on highly active antiretroviral therapy with low CD4 T cell restoration.

1 reference

https://api.crossref.org/works/10.1111%2FCEI.12278

21 January 2018

Plasma HIV-1 RNA detection below 50 copies/ml and risk of virologic rebound in patients receiving highly active antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1111%2FCEI.12278

21 January 2018

Ultrasensitive assessment of residual low-level HIV viremia in HAART-treated patients and risk of virological failure

1 reference

https://api.crossref.org/works/10.1111%2FCEI.12278

21 January 2018

The significance of very low-level viraemia detected by sensitive viral load assays in HIV infected patients on HAART.

1 reference

https://api.crossref.org/works/10.1111%2FCEI.12278

21 January 2018

Persistent low-level HIV-1 RNA between 20 and 50 copies/mL in antiretroviral-treated patients: associated factors and virological outcome

1 reference

https://api.crossref.org/works/10.1111%2FCEI.12278

21 January 2018

Low-level viremia and proviral DNA impede immune reconstitution in HIV-1-infected patients receiving highly active antiretroviral therapy.

1 reference

https://api.crossref.org/works/10.1111%2FCEI.12278

21 January 2018

Regulatory T cells in HIV infection: pathogenic or protective participants in the immune response?

1 reference

https://api.crossref.org/works/10.1111%2FCEI.12278

21 January 2018

Immunology. Immunity benefits from a little suppression.

1 reference

https://api.crossref.org/works/10.1111%2FCEI.12278

21 January 2018

Coordination of early protective immunity to viral infection by regulatory T cells

1 reference

https://api.crossref.org/works/10.1111%2FCEI.12278

21 January 2018

Homeostasis and function of regulatory T cells in HIV/SIV infection

1 reference

https://api.crossref.org/works/10.1111%2FCEI.12278

21 January 2018

Poor immune reconstitution in HIV-infected patients associates with high percentage of regulatory CD4+ T cells

1 reference

https://api.crossref.org/works/10.1111%2FCEI.12278

21 January 2018

Memory and naive-like regulatory CD4+ T cells expand during HIV-2 infection in direct association with CD4+ T-cell depletion irrespectively of viremia.

1 reference

https://api.crossref.org/works/10.1111%2FCEI.12278

21 January 2018

HIV-1-driven regulatory T-cell accumulation in lymphoid tissues is associated with disease progression in HIV/AIDS.

1 reference

https://api.crossref.org/works/10.1111%2FCEI.12278

21 January 2018

The relationship of T-regulatory cell subsets to disease stage, immune activation, and pathogen-specific immunity in HIV infection.

1 reference

https://api.crossref.org/works/10.1111%2FCEI.12278

21 January 2018

Proportions of circulating T cells with a regulatory cell phenotype increase with HIV-associated immune activation and remain high on antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1111%2FCEI.12278

21 January 2018

CD4(+)CD25(+/hi)CD127(lo) phenotype does not accurately identify regulatory T cells in all populations of HIV-infected persons

1 reference

https://api.crossref.org/works/10.1111%2FCEI.12278

21 January 2018

Immune exhaustion occurs concomitantly with immune activation and decrease in regulatory T cells in viremic chronically HIV-1-infected patients

1 reference

https://api.crossref.org/works/10.1111%2FCEI.12278

21 January 2018

Preservation of FoxP3+ regulatory T cells in the peripheral blood of human immunodeficiency virus type 1-infected elite suppressors correlates with low CD4+ T-cell activation.

1 reference

https://api.crossref.org/works/10.1111%2FCEI.12278

21 January 2018

FOXP3+ regulatory T cells in the human immune system

1 reference

https://api.crossref.org/works/10.1111%2FCEI.12278

21 January 2018

Low-level viremia is associated with non-B subtypes in patients infected with HIV with virological success following HAART introduction

1 reference

https://api.crossref.org/works/10.1111%2FCEI.12278

21 January 2018

Assessment of a novel flow cytometry technique of one-step intracellular staining: example of FOXP3 in clinical samples.

1 reference

https://api.crossref.org/works/10.1111%2FCEI.12278

21 January 2018

Immune activation, apoptosis, and Treg activity are associated with persistently reduced CD4+ T-cell counts during antiretroviral therapy.

1 reference

https://api.crossref.org/works/10.1111%2FCEI.12278

21 January 2018

High IL-10 production by aged AIDS patients is related to high frequency of Tr-1 phenotype and low in vitro viral replication.

1 reference

https://api.crossref.org/works/10.1111%2FCEI.12278

21 January 2018

Factors associated with paradoxical immune response to antiretroviral therapy in HIV infected patients: a case control study

1 reference

https://api.crossref.org/works/10.1111%2FCEI.12278

21 January 2018

Altered frequency and phenotype of CD4+ forkhead box protein 3+ T cells and its association with autoantibody production in human immunodeficiency virus-infected paediatric patients.

1 reference

https://api.crossref.org/works/10.1111%2FCEI.12278

21 January 2018

Enhanced CD4+ T-cell recovery with earlier HIV-1 antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1111%2FCEI.12278

21 January 2018

Regulatory T cells in human immunodeficiency virus-infected patients are elevated and independent of immunological and virological status, as well as initiation of highly active anti-retroviral therapy

1 reference

https://api.crossref.org/works/10.1111%2FCEI.12278

21 January 2018

HIV-specific regulatory T cells are associated with higher CD4 cell counts in primary infection

1 reference

https://api.crossref.org/works/10.1111%2FCEI.12278

21 January 2018

Foxp3 programs the development and function of CD4+CD25+ regulatory T cells

1 reference

https://api.crossref.org/works/10.1111%2FCEI.12278

21 January 2018

Natural regulatory T cells in infectious disease

1 reference

https://api.crossref.org/works/10.1111%2FCEI.12278

21 January 2018

Early and long-lasting alteration of effector CD45RA(-)Foxp3(high) regulatory T-cell homeostasis during HIV infection

1 reference

https://api.crossref.org/works/10.1111%2FCEI.12278

21 January 2018

Immunologic and clinical effects of antibody blockade of cytotoxic T lymphocyte-associated antigen 4 in previously vaccinated cancer patients

1 reference

https://api.crossref.org/works/10.1111%2FCEI.12278

21 January 2018

Regulatory-T-cell inhibition versus depletion: the right choice in cancer immunotherapy

1 reference

https://api.crossref.org/works/10.1111%2FCEI.12278

21 January 2018

Reduced thymic output is a major mechanism of immune reconstitution failure in HIV-infected patients after long-term antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1111%2FCEI.12278

21 January 2018

Differential upregulation of CD38 on different T-cell subsets may influence the ability to reconstitute CD4+ T cells under successful highly active antiretroviral therapy.

1 reference

https://api.crossref.org/works/10.1111%2FCEI.12278

21 January 2018

Immune Reconstitution During the First Year of Antiretroviral Therapy of HIV-1-Infected Adults in Rural Burkina Faso

1 reference

https://api.crossref.org/works/10.1111%2FCEI.12278

21 January 2018

Regulatory T cells and chronic immune activation in human immunodeficiency virus 1 (HIV-1)-infected children

1 reference

https://api.crossref.org/works/10.1111%2FCEI.12278

21 January 2018

Increased frequency of regulatory T cells accompanies increased immune activation in rectal mucosae of HIV-positive noncontrollers

1 reference

https://api.crossref.org/works/10.1111%2FCEI.12278

21 January 2018

A low T regulatory cell response may contribute to both viral control and generalized immune activation in HIV controllers

1 reference

https://api.crossref.org/works/10.1111%2FCEI.12278

21 January 2018

Level, phenotype and activation status of CD4+FoxP3+regulatory T cells in patients chronically infected with human immunodeficiency virus and/or hepatitis C virus

1 reference

https://api.crossref.org/works/10.1111%2FCEI.12278

21 January 2018

T-Cell Dysfunction in HIV-1-Infected Patients With Impaired Recovery of CD4 Cells Despite Suppression of Viral Replication

1 reference

https://api.crossref.org/works/10.1111%2FCEI.12278

21 January 2018

CD4+CD25+CD127- assessment as a surrogate phenotype for FOXP3+ regulatory T cells in HIV-1 infected viremic and aviremic subjects

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4008985

4 November 2018

Severe immune dysregulation affects CD4⁺CD25(hi)FoxP3⁺ regulatory T cells in HIV-infected patients with low-level CD4 T-cell repopulation despite suppressive highly active antiretroviral therapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4008985

4 November 2018

Factors influencing T cell activation and programmed death 1 expression in HIV-infected children

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4008985

4 November 2018

Nadir CD4 T Cell Count as Predictor and High CD4 T Cell Intrinsic Apoptosis as Final Mechanism of Poor CD4 T Cell Recovery in Virologically Suppressed HIV‐Infected Patients: Clinical Implications

1 reference

https://api.crossref.org/works/10.1111%2FCEI.12278

21 January 2018

Residual viraemia does not influence 1 year virological rebound in HIV-infected patients with HIV RNA persistently below 50 copies/mL

1 reference

https://api.crossref.org/works/10.1111%2FCEI.12278

21 January 2018

Circulating interleukin-6 levels correlate with residual HIV viraemia and markers of immune dysfunction in treatment-controlled HIV-infected patients

1 reference

https://api.crossref.org/works/10.1111%2FCEI.12278

21 January 2018

The significance of activation markers on CD8 lymphocytes in human immunodeficiency syndrome: staging and prognostic value

1 reference

https://pubmed.ncbi.nlm.nih.gov/24460818

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical Outcome of Patients with HIV-1 Infection according to Immunologic and Virologic Response after 6 Months of Highly Active Antiretroviral Therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/24460818

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

HIV-infected adults with a CD4 cell count greater than 500 cells/mm3 on long-term combination antiretroviral therapy reach same mortality rates as the general population

1 reference

https://pubmed.ncbi.nlm.nih.gov/24460818

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The decrease of regulatory T cells correlates with excessive activation and apoptosis of CD8+ T cells in HIV-1-infected typical progressors, but not in long-term non-progressors

1 reference

https://pubmed.ncbi.nlm.nih.gov/24460818

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1111/CEI.12278

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24460818%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

release_pjgkb3pc3rairig7qnwyejhsz4

1 reference

https://api.fatcat.wiki/v0/release/pjgkb3pc3rairig7qnwyejhsz4

24 November 2022

based on heuristic

mapped directly with Wikidata item

PMC publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24460818%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39422439&oldid=1843321175"